French researchers are planning to test nicotine patches on COVID-19 patients.

The study which is based on a hypothesis confirms that French researchers are planning to test nicotine patches on COVID-19 patients.

The study which is based on a hypothesis confirms that French researchers are planning to test nicotine patches on COVID-19 patients.The Pitie-Salpetriere report published by Qeios said that based on the current scientific studies and epidemiological data the current smoking status appears to be a protective factor against the infection by COVID-19. To prevent the infection and the retro-propagation of the virus through the Central Nerves System (CNS), that researchers have planned a therapeutic test against COVID-19 with nicotine (and other nicotinic agents) patches or other delivery methods (like sniffing/chewing) in hospitalized patients and the general population.

The New York Post, citing The Guardian reported that the French researchers are planning to examine whether nicotine patches could help prevent or lessen the effects of COVID-19. The study will test nicotine patches on COVID-19 patients and frontline health care workers. It also added that the researchers are awaiting approval from health authorities in France to carry out further clinical trials.

The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.